Browse > Article
http://dx.doi.org/10.3904/kjim.2013.28.4.420

The dose of cyclophosphamide for treating paraquat-induced rat lung injury  

Choi, Jae-Sung (Department of Internal Medicine, Soonchunhyang University Cheonan Hospital)
Jou, Sung-Shick (Department of Radiology, Soonchunhyang University Cheonan Hospital)
Oh, Mee-Hye (Department of Pathology, Soonchunhyang University Cheonan Hospital)
Kim, Young-Hee (Department of Microbiology, Soonchunhyang University College of Medicine)
Park, Min-Ju (Department of Microbiology, Soonchunhyang University College of Medicine)
Gil, Hyo-Wook (Department of Internal Medicine, Soonchunhyang University Cheonan Hospital)
Song, Ho-Yeon (Department of Microbiology, Soonchunhyang University College of Medicine)
Hong, Sae-Yong (Department of Internal Medicine, Soonchunhyang University Cheonan Hospital)
Publication Information
The Korean journal of internal medicine / v.28, no.4, 2013 , pp. 420-427 More about this Journal
Abstract
Background/Aims: Cyclophosphamide (CP) is a promising treatment for severe cases of paraquat (PQ) poisoning. We investigated the effective dose of CP for mitigating PQ-induced lung injury. Methods: Adult male Sprague-Dawley rats were allocated into five groups: control, PQ (35 mg/kg, intraperitoneal injection), and PQ + CP (1.5, 15, or 30 mg/kg). The dimensions of lung lesions were determined using X-ray microtomography (micro-CT), and histological changes and cytokine levels were recorded. Results: The micro-CT results showed that 15 mg/kg CP was more effective than 1.5 mg/kg CP for treating PQ-induced lung injury. At a dose of 1.5 mg/kg, CP alleviated the histological evidence of inflammation and altered superoxide dismutase activity. Using 15 mg/kg CP reduced the elevated catalase activity and serum transforming growth factor (TGF)-${\beta}1$ level. Conclusions: A CP dose of > 15 mg/kg is effective for reducing the severity of PQ-induced lung injury as determined by histological and micro-CT tissue examination, possibly by modulating antioxidant enzyme and TGF-${\beta}1$ levels.
Keywords
Paraquat; Cyclophosphamide; Reactive oxygen species; X-ray microtomography;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Hampson EC, Pond SM. Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning: a retrospective review of 42 patients. Med Toxicol Adverse Drug Exp 1988;3:64-71.   DOI
2 Talbot AR, Barnes MR. Radiotherapy for the treatment of pulmonary complications of paraquat poisoning. Hum Toxicol 1988;7:325-332.   DOI
3 Bateman DN. Pharmacological treatments of paraquat poisoning. Hum Toxicol 1987;6:57-62.   DOI
4 Hong SY, Gil HW, Yang JO, et al. Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci 2005;20:721-726.   DOI   ScienceOn
5 Dinis-Oliveira RJ, Duarte JA, Sanchez-Navarro A, Remiao F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 2008;38:13-71.   DOI   ScienceOn
6 Dinis-Oliveira RJ, Remiao F, Duarte JA, et al. P-glycoprotein induction: an antidotal pathway for paraquatinduced lung toxicity. Free Radic Biol Med 2006;41:1213-1224.   DOI   ScienceOn
7 Lin NC, Lin JL, Lin-Tan DT, Yu CC. Combined initial cyclophosphamide with repeated methylprednisolone pulse therapy for severe paraquat poisoning from dermal exposure. J Toxicol Clin Toxicol 2003;41:877-881.   DOI   ScienceOn
8 Lin JL, Lin-Tan DT, Chen KH, Huang WH. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 2006;34:368-373.   DOI   ScienceOn
9 Lin JL, Leu ML, Liu YC, Chen GH. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med 1999;159:357-360.   DOI   ScienceOn
10 Chen GH, Lin JL, Huang YK. Combined methylprednisolone and dexamethasone therapy for paraquat poisoning. Crit Care Med 2002;30:2584-2587.   DOI   ScienceOn
11 Eddleston M, Wilks MF, Buckley NA. Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. QJM 2003;96:809-824.   DOI   ScienceOn
12 Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999;5:555-560.
13 Gould VE, Miller J. Sclerosing alveolitis induced by cyclophosphamide: ultrastructural observations on alveolar injury and repair. Am J Pathol 1975;81:513-530.
14 Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity associated with cyclophosphamide use: two distinct patterns. Am J Respir Crit Care Med 1996;154(6 Pt 1):1851-1856.   DOI   ScienceOn
15 Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 1979;120:893-899.
16 Perriens JH, Benimadho S, Kiauw IL, Wisse J, Chee H. High-dose cyclophosphamide and dexamethasone in paraquat poisoning: a prospective study. Hum Exp Toxicol 1992;11:129-134.   DOI   ScienceOn
17 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.   DOI   ScienceOn
18 Kang MS, Gil HW, Yang JO, Lee EY, Hong SY. Comparison between kidney and hemoperfusion for paraquat elimination. J Korean Med Sci 2009;24 Suppl:S156-S160.   DOI   ScienceOn
19 Afzali S, Gholyaf M. The effectiveness of combined treatment with methylprednisolone and cyclophosphamide in oral paraquat poisoning. Arch Iran Med 2008;11:387-391.
20 Addo E, Poon-King T. Leucocyte suppression in treatment of 72 patients with paraquat poisoning. Lancet 1986;1:1117-1120.
21 Lee J, Kwon W, Jo Y, Suh G, Youn Y. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Hum Exp Toxicol 2008;27:49-54.   DOI
22 Chang X, Shao C, Wu Q, Huang M, Zhou Z. Pyrrolidine dithiocarbamate attenuates paraquat-induced lung injury in rats. J Biomed Biotechnol 2009;2009:619487.
23 Border WA, Ruoslahti E. Transforming growth factorbeta in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.   DOI
24 Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003;58:772-777.   DOI   ScienceOn
25 Zhi Q, Sun H, Qian X, Yang L. Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat? Int Immunopharmacol 2011;11:96-102.   DOI   ScienceOn
26 Zhi QM, Yang LT, Sun HC. Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats. Intern Med 2011;50:1879-1887.   DOI
27 Ahmed AA. Protective effect of montelukast on paraquat-induced lung toxicity in rats. Biosci Trends 2009;3:63-72.
28 Lee KH, Gil HW, Kim YT, Yang JO, Lee EY, Hong SY. Marked recovery from paraquat-induced lung injury during long-term follow-up. Korean J Intern Med 2009;24:95-100.   DOI   ScienceOn
29 Kim YT, Jou SS, Lee HS, et al. The area of ground glass opacities of the lungs as a predictive factor in acute paraquat intoxication. J Korean Med Sci 2009;24:636-640.   DOI   ScienceOn